http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0130332-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_457a7761bb0b0ae89f3bf95bbc5d08a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6a948dd6114723185d1890a7ebb68cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4436
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2000-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a9f922b2969c4338c14ea22d0895ebe
publicationDate 2002-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0130332-A3
titleOfInvention Methods of protecting neuronal function
abstract The present invention is generally directed to potassium adenosine triphosphate ('KATP') channel opening compositions. The present invention also relates to the use of KATP channel openers in therapeutic applications. The KATP channel opening compositions of the present invention include diazoxide (7-chloro-3-methyl-2H-1,2,4-benzo-thiadiazine 1,1-dioxide) and aprikalim. According to the present invention, diazoxide and aprikalim can be used independently, or in combination. The present also relates to therapeutic methods for protecting neuronal function utilizing KATP channel openers. Methods of the present invention may be advantageous for protecting neuronal function, prior to medical procedures, after stroke-like events or other events associated with reductions in blood flow, and/or for preserving tissues or organs against cellular injury and death during removal, storage, transplantation or reattachment.
priorityDate 1999-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451731360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413377870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129651106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87483892
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23681163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87483899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226585508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229178446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9571083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448695463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229178475

Total number of triples: 34.